title: [Health economic evaluation of human papillomavirus vaccines in the developing countries: systematic reviews].
abstract: Cervical carcinoma has brought huge burden on patients, especially in developing countries. Preventive vaccines could effectively reduce the incidence of cervical carcinoma. The high prices were one of the most difficult problem in introducing the vaccine in developing countries, so the cost-effectiveness and health financing of the vaccines should be carefully studied before incorporated into the national immunization program. Thus, researchers used mathematical models to predict the effects of HPV vaccines and to study the cost- effectiveness. In order to understand the current situation on the cost-effectiveness of HPV vaccines in the developing countries, a systematic searching of literature from PubMed, Elsevier Science Direct, Medline, ProQuest, CNKI and Wangfang Data was performed, this study aims to conduct a systematic review from aspects of project source, first author, research areas, research perspectives, prevention strategies, vaccine characteristics, cost-effectiveness.
authors.affiliation: The School of Economics, Xiamen University, Xiamen 361005, China.
authors.forename: Xiaobin
authors.initials: X
authors.lastname: Song
authors.forename: Fanzhen
authors.initials: F
authors.lastname: Mao
authors.forename: Zi
authors.initials: Z
authors.lastname: Zhou
authors.forename: Qinjian
authors.initials: Q
authors.lastname: Zhao
authors.forename: Ya
authors.initials: Y
authors.lastname: Fang
mesh_terms: D003362:Cost-Benefit Analysis; D003906:Developing Countries; D005260:Female; D006801:Humans; D017589:Immunization Programs; D015994:Incidence; D008962:Models, Theoretical; D030361:Papillomavirus Infections / Q000191:economics / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000191:economics*; D002583:Uterine Cervical Neoplasms / Q000191:economics / Q000517:prevention & control*
chemical_list: D053918:Papillomavirus Vaccines